advertisement
11.4 Prostaglandins (53)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins77690 Effect of Latanoprost on Choroidal Thickness
Sahinoglu-Keskek N
Journal of Glaucoma 2018; 27: 635-637
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Iwamura R
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78189 Effect of long-term topical latanoprost medication on conjunctival thickness in patients with glaucoma
Li QS
International Journal of Ophthalmology 2018; 11: 1158-1162
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Iwamura R
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78181 Topical Treatment of Eyebrow Hypotrichosis with Bimatoprost 0.03% Solution: Case Report and Literature Review
Riahi RR
Cureus 2018; 10: e2666
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Fuwa M
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Misiuk-Hojlo M
European Journal of Ophthalmology 2018; 0: 1120672118785280
78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Fahmy HM
International Journal of Pharmaceutics 2018; 548: 597-608
78237 Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
Inoue K
Open Ophthalmology Journal 2018; 12: 121-126
78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Mancino R; Di Carlo E
Open Ophthalmology Journal 2018; 12: 110-120
78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Pomorska M
European Journal of Ophthalmology 2018; 0: 1120672118785280
77690 Effect of Latanoprost on Choroidal Thickness
Canan H
Journal of Glaucoma 2018; 27: 635-637
78189 Effect of long-term topical latanoprost medication on conjunctival thickness in patients with glaucoma
Bao FF
International Journal of Ophthalmology 2018; 11: 1158-1162
78181 Topical Treatment of Eyebrow Hypotrichosis with Bimatoprost 0.03% Solution: Case Report and Literature Review
Cohen PR
Cureus 2018; 10: e2666
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Toris CB
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Saad EAES
International Journal of Pharmaceutics 2018; 548: 597-608
78237 Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
Ueda T
Open Ophthalmology Journal 2018; 12: 121-126
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Tanaka M
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Napoli D
Open Ophthalmology Journal 2018; 12: 110-120
78105 Treatment merits of Latanoprost/Thymoquinone - Encapsulated liposome for glaucomatus rabbits
Sabra NM
International Journal of Pharmaceutics 2018; 548: 597-608
78091 Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
Fan S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 531-537
78237 Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma
Ishida K
Open Ophthalmology Journal 2018; 12: 121-126
78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Mulak M
European Journal of Ophthalmology 2018; 0: 1120672118785280
78100 Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl
Okanari E
Journal of Medicinal Chemistry 2018; 61: 6869-6891
78189 Effect of long-term topical latanoprost medication on conjunctival thickness in patients with glaucoma
Zhang ZY; Ma K
International Journal of Ophthalmology 2018; 11: 1158-1162